2014
DOI: 10.1097/mca.0000000000000116
|View full text |Cite
|
Sign up to set email alerts
|

Statins and prevention of stent-related late adverse events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…12 In the cardiovascular literature, several studies have demonstrated that statin therapy improved neointimal coverage of drugeluting stents and also reduced rates of neointimal hyperplasia. 4,[13][14][15][16] In addition, statin use has also been shown to improve short-term mortality rates in patients receiving stent placement for acute coronary syndrome due to reductions in thrombotic complication rates. In a study of Ͼ1500 patients, Tentzeris et al 5 found that patients on high-dose statin therapy had lower odds of mortality at 3 months.…”
Section: Discussionmentioning
confidence: 99%
“…12 In the cardiovascular literature, several studies have demonstrated that statin therapy improved neointimal coverage of drugeluting stents and also reduced rates of neointimal hyperplasia. 4,[13][14][15][16] In addition, statin use has also been shown to improve short-term mortality rates in patients receiving stent placement for acute coronary syndrome due to reductions in thrombotic complication rates. In a study of Ͼ1500 patients, Tentzeris et al 5 found that patients on high-dose statin therapy had lower odds of mortality at 3 months.…”
Section: Discussionmentioning
confidence: 99%